MAPT and Alzheimer disease: Increased levels of RCAN1 also induce the expression of glycogen synthase kinase 3β (GSK-3β) the main kinase related to tau hyperphosphorylation in AD [15], thereby accelerating the formation of hyperphosphorylated tau.